S&P 500
(-0.16%) 5 464.62 points
Dow Jones
(0.04%) 39 150 points
Nasdaq
(-0.18%) 17 689 points
Oil
(-1.87%) $80.63
Gas
(-1.17%) $2.71
Gold
(-1.44%) $2 334.90
Silver
(-4.04%) $29.58
Platinum
(1.17%) $995.80
USD/EUR
(0.11%) $0.935
USD/NOK
(0.25%) $10.57
USD/GBP
(0.07%) $0.790
USD/RUB
(2.13%) $89.13

Realtime updates for Biocept Inc [BIOC]

Exchange: NASDAQ Sector: Healthcare Industry: Diagnostics & Research
Last Updated4 Jun 2024 @ 16:00

0.00% $ 0.435

Live Chart Being Loaded With Signals

Commentary (4 Jun 2024 @ 16:00):

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample...

Stats
Today's Volume 572 521
Average Volume 0
Market Cap 0.00
EPS $-3.50 ( Q2 | 2023-08-14 )
Next earnings date ( $0 ) 2024-08-12
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.0100
(Sector) 42.63
(Industry) 0
ATR14 $0.149 (281.13%)
ACRS 1.77%
AKU -17.87%
APDN 0.04%
BDSX 6.21%
BIOC 0.00%
BNGO -6.81%
BNR -1.04%
CDNA 0.64%
CEMI 0.22%
CHEK -3.83%
CNTG -9.79%
CSTL 1.52%
DMTK -3.14%
DRIO 11.01%
EXAS 1.93%
FLDM -7.02%
FLGT 1.10%
GENE 3.03%
GH 0.00%
GTH 0.12%
HTGM 0.00%
ICLR 0.88%
IDXX -0.05%
ILMN 0.30%
ISPC -5.86%
LAB 0.52%
LMDX 0.00%
MDXH -1.50%
ME 1.39%
MEDP 0.85%
MYGN 1.93%
MYNZ -19.82%
NDRA 3.04%
NEO 1.23%
NEOG 0.42%
NOTV 4.65%
NTRA -0.08%
OCDX 0.92%
OLK 0.31%
OPGN 2.12%
OPK -1.61%
PMD 2.62%
PRPO -3.30%
PSNL -0.81%
RDNT 2.55%
SERA -6.21%
SHC 3.71%
SQL 0.00%
STIM 2.23%
STRR -2.93%
STRRP 3.89%
SYNH 0.02%
TRIB -0.80%
TTOO 2.95%
TWST 4.58%
VIVO 0.00%
XGN 0.00%
Insider Trading
Date Person Action Amount type
2023-06-16 Walsh Robert Sell 806 Employee Stock option (right to buy)
2022-11-17 Dao-haddock Quyen Thi Buy 10 000 Employee Stock Option (right to buy)
2022-11-17 Dao-haddock Quyen Thi Buy 0
2022-11-17 Dao-haddock Quyen Thi Buy 0
2022-07-08 Chandler Marsha Alpert Buy 10 000 Employee Stock Option (right to buy)
INSIDER POWER
86.44
Last 94 transactions
Buy: 4 462 700 | Sell: 1 536 257

Volume Correlation

Long: 0.09 (neutral)
Short: 0.26 (neutral)
Signal:(25.06) Neutral

Biocept Inc Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Biocept Inc Correlation - Currency/Commodity

The country flag 0.78
( moderate )
The country flag 0.78
( moderate )
The country flag 0.67
( moderate )
The country flag 0.70
( moderate )
The country flag -0.48
( neutral )
The country flag -0.78
( moderate negative )

Biocept Inc Financials

Annual 2022
Revenue: $25.86M
Gross Profit: $-2.58M (-9.99 %)
EPS: $-56.78
FY 2022
Revenue: $25.86M
Gross Profit: $-2.58M (-9.99 %)
EPS: $-56.78
FY 2021
Revenue: $61.25M
Gross Profit: $23.49M (38.34 %)
EPS: $-0.190
FY 2020
Revenue: $27.46M
Gross Profit: $6.12M (22.30 %)
EPS: $-1.500

Financial Reports:

No articles found.

Biocept Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Biocept Inc

Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The company offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer (NSCLC), gastric cancer, colorectal cancer, prostate cancer, pancreaticobiliary cancer, and ovarian cancer. It also provides cerebrospinal fluid tumor cell and ctDNA and ctRNA testing services to medical oncologists, neuro-oncologists, surgical oncologists, urologists, pulmonologists, pathologists, and other physicians; clinical trial and research services to pharmaceutical companies, biopharmaceutical companies and clinical research organizations; and RT-PCR testing services for COVID-19. The company has a collaboration with CLEARED4 to develop a system for tracking and managing COVID-19 testing requirements and test results for its customers; and with Protean BioDiagnostics, Inc. to research the ability of its Target Selector molecular assay to determine EGFR status in NSCLC patients. Biocept, Inc. was incorporated in 1997 and is headquartered in San Diego, California.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.5191428661346 seconds
Number of API calls: 3
Number of DB calls: 9